Compare Lustrum:HISAMITSU PHARMACEUTICAL CO.,INC.:4530

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index HISAMITSU PHARMACEUTICAL CO.,INC. Go to web site 4530 Medicals 東証プライム February 1, 2000 1962.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

HISAMITSU PHARMACEUTICAL CO.,INC. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

HISAMITSU PHARMACEUTICAL CO.,INC. Balance Sheet 2025年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Balance Sheet 2024年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Balance Sheet 2023年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Balance Sheet 2022年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Balance Sheet 2021年2月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date February 28, 2025 February 29, 2024 February 28, 2023 February 28, 2022 February 28, 2021
Cash and Cash Equivalents
(Percent)
114,518up
(33.4%)down
112,459down
(34.2%)down
122,154down
(38.9%)down
129,290up
(42.7%)up
114,254
(38.1%)
Other Current AssetsHelp
(Percent)
89,270up
(26.0%)up
81,563up
(24.8%)up
77,020up
(24.5%)up
70,886down
(23.4%)down
83,807
(27.9%)
Tangible Fixed AssetsHelp
(Percent)
59,899up
(17.5%)up
49,462up
(15.0%)up
43,209up
(13.8%)up
39,069up
(12.9%)up
37,354
(12.5%)
Intangible Fixed AssetHelp
(Percent)
4,680down
(1.4%)down
5,387up
(1.6%)up
946down
(0.3%)down
1,326up
(0.4%)up
1,178
(0.4%)
Investments and OthersHelp
(Percent)
74,701down
(21.8%)down
78,614up
(23.9%)up
69,144up
(22.0%)up
60,843down
(20.1%)down
63,268
(21.1%)
Total AssetsHelp
(Percent)
343,068
(100%)
328,779
(100%)
313,917
(100%)
302,858
(100%)
299,861
(100%)
Total Current LiabilitiesHelp
(Percent)
63,862up
(18.6%)down
63,223up
(19.2%)up
56,654up
(18.0%)up
48,602up
(16.0%)up
47,172
(15.7%)
Total Long-term LiabilitiesHelp
(Percent)
2,382up
(0.7%)up
679down
(0.2%)down
897down
(0.3%)down
1,088up
(0.4%)up
390
(0.1%)
Shareholder's EquityHelp
(Percent)
276,824up
(80.7%)up
264,877up
(80.6%)down
256,366up
(81.7%)down
253,168up
(83.6%)down
252,299
(84.1%)
Total LiabilitiesHelp
(Percent)
343,068
(100%)
328,779
(100%)
313,917
(100%)
302,858
(100%)
299,861
(100%)

HISAMITSU PHARMACEUTICAL CO.,INC. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

HISAMITSU PHARMACEUTICAL CO.,INC. Profit and Loss Account 2025年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Profit and Loss Account 2024年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Profit and Loss Account 2023年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Profit and Loss Account 2022年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Profit and Loss Account 2021年2月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date February 28, 2025 February 29, 2024 February 28, 2023 February 28, 2022 February 28, 2021
Amount of Sales
(Percent)
156,006
(100%)
141,706
(100%)
128,330
(100%)
120,193
(100%)
114,510
(100%)
Total Sales
(Percent)
156,006
(100%)
141,706
(100%)
128,330
(100%)
120,193
(100%)
114,510
(100%)
Cost of SalesHelp
(Percent)
64,810up
(41.5%)down
62,735up
(44.3%)up
55,630up
(43.3%)up
50,126up
(41.7%)up
45,337
(39.6%)
Other Costs and RevenueHelp 69,437up
(44.5%)down
65,000up
(45.9%)down
60,957up
(47.5%)down
60,408up
(50.3%)down
59,922
(52.3%)
Total CostsHelp 134,247 127,735 116,587 110,534 105,259
Net RevenueHelp 91,196up
(58.5%)up
78,971up
(55.7%)down
72,700up
(56.7%)down
70,067up
(58.3%)down
69,173
(60.4%)
Earnings Before TaxHelp 28,687up
(18.4%)up
19,186up
(13.5%)up
16,113up
(12.6%)up
12,956up
(10.8%)up
12,197
(10.7%)
Net IncomeHelp 21,759up
(13.9%)up
13,971up
(9.9%)up
11,743up
(9.2%)up
9,659up
(8.0%)down
9,251
(8.1%)
当期純利益 21,759 13,971 11,743 9,659 9,251

HISAMITSU PHARMACEUTICAL CO.,INC. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

HISAMITSU PHARMACEUTICAL CO.,INC. Cash Flow Statement 2025年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Cash Flow Statement 2024年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Cash Flow Statement 2023年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Cash Flow Statement 2022年2月期 HISAMITSU PHARMACEUTICAL CO.,INC. Cash Flow Statement 2021年2月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date February 28, 2025 February 29, 2024 February 28, 2023 February 28, 2022 February 28, 2021
Operating Cash Flow(OFC)Help
(Percent)
18,765up
(47.8%)down
18,187up
(90.3%)up
12,728down
(33.0%)down
19,199up
(68.0%)up
5,288
(40.4%)
Investing Cash Flow(ICF)Help
(Percent)
17,563up
(44.7%)up
-2,512up
(-12.5%)up
-23,868down
(-61.9%)down
-13,060down
(-46.2%)down
7,815
(59.6%)
Financing Cash FlowHelp
(Percent)
-15,850up
(-40.4%)up
-16,691down
(-82.9%)down
-14,687up
(-38.1%)up
-15,189down
(-53.8%)up
-7,187
(-54.9%)
Exchange Difference of Cash and Cash EquivalentsHelp
(Percent)
2,936up
(7.5%)down
1,957down
(9.7%)down
5,005up
(13.0%)down
3,944up
(14.0%)up
-1,559
(-11.9%)
Net Increase and Decrease in Cash and Cash Equivalentsn 23,414up
(59.6%)up
941up
(4.7%)up
-20,822down
(-54.0%)down
-5,106down
(-18.1%)down
4,357
(33.3%)

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

HISAMITSU PHARMACEUTICAL CO.,INC.
TYO Inc.
FUJITSU BROAD SOLUTION & CONSULTING Inc.
SURUGA CORPORATION
Euglena Co.,Ltd.

Company where related level is highHelp

PRISM BioLab
Solasia Pharma K.K.
RIBOMIC Inc.
Toyama Chemical Co.,Ltd.
Cyfuse Biomedical K.K.
R-TECH UENO,LTD.
K Pharma,Inc.
Kubota Pharmaceutical Holdings Co.,Ltd.
EIKEN CHEMICAL CO.,LTD.
KAKEN PHARMACEUTICAL CO.,LTD.